Cancer Biomarkers Market (Type: Protein, Genetics, and Others; and Type of Cancer: Lung, Breast, Leukemia, Melanoma, Colorectal, Prostate, Ovarian, Liver, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Sep 2022| TMR3303A| Transparency

Report Highlights

Cancer Biomarkers Market – Scope of Report

TMR’s report on the global cancer biomarkers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global cancer biomarkers market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cancer biomarkers market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the cancer biomarkers market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cancer biomarkers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global cancer biomarkers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cancer biomarkers market.

The report delves into the competitive landscape of the global cancer biomarkers market. Key players operating in the global cancer biomarkers market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global cancer biomarkers market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market cancer biomarkers.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

  • Company websites, presentations, annual reports, white papers, technical paper, product brochure
  • Internal and external proprietary databases and relevant patents
  • National government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

  • Industry Sources:
  • WorldWideScience.org
  • Elsevier, Inc.
  • National Institutes of Health (NIH)
  • PubMed
  • NCBI
  • Department of Health Care Service
  • Trade Data Sources
  • Trade Map
  • UN Comtrade
  • Trade Atlas
  • Company Information
  • OneSource Business Browser
  • Hoover’s
  • Factiva
  • Bloomberg
  • Mergers & Acquisitions
  • Thomson Mergers & Acquisitions
  • MergerStat
  • Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

  • Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
  • Purchasing/Sourcing managers, technical personnel, distributors
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • Hitachi, Ltd.
  • IBA Worldwide
  • Mevion Medical Systems, Inc.

 

 

Frequently Asked Questions (FAQs)

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others

Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

  • Table 1 : Global Cancer Biomarkers Market Value (US$ Mn) Forecast, by Type, 2017‒2031
  • Table 2 : Global Cancer Biomarkers Market Value (US$ Mn) Forecast, by Type of Cancer, 2017–2031
  • Table 3 : Global Cancer Biomarkers Market Value (US$ Mn) Forecast, by Technology, 2017–2031
  • Table 4 : Global Cancer Biomarkers Market Value (US$ Mn) Forecast, by Application, 2017–2031
  • Table 5 : Global Cancer Biomarkers Market Value (US$ Mn) Forecast, by Region, 2017–2031
  • Table 6 : North America Cancer Biomarkers Market Value (US$ Mn) Forecast, by Country, 2017–2031
  • Table 7 : North America Cancer Biomarkers Market Value (US$ Mn) Forecast, by Type, 2017‒2031
  • Table 8 : North America Cancer Biomarkers Market Value (US$ Mn) Forecast, by Type of Cancer, 2017–2031
  • Table 9 : North America Cancer Biomarkers Market Value (US$ Mn) Forecast, by Technology, 2017–2031
  • Table 10 : North America Cancer Biomarkers Market Value (US$ Mn) Forecast, by Application, 2017–2031
  • Table 11 : Europe Cancer Biomarkers Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
  • Table 12 : Europe Cancer Biomarkers Market Value (US$ Mn) Forecast, by Type, 2017‒2031
  • Table 13 : Europe Cancer Biomarkers Market Value (US$ Mn) Forecast, by Type of Cancer, 2017–2031
  • Table 14 : Europe Cancer Biomarkers Market Value (US$ Mn) Forecast, by Technology, 2017–2031
  • Table 15 : Europe Cancer Biomarkers Market Value (US$ Mn) Forecast, by Application, 2017–2031
  • Table 16 : Asia Pacific Cancer Biomarkers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 17 : Asia Pacific Cancer Biomarkers Market Value (US$ Mn) Forecast, by Type, 2017‒2031
  • Table 18 : Asia Pacific Cancer Biomarkers Market Value (US$ Mn) Forecast, by Type of Cancer, 2017–2031
  • Table 19 : Asia Pacific Cancer Biomarkers Market Value (US$ Mn) Forecast, by Technology, 2017–2031
  • Table 20 : Asia Pacific Cancer Biomarkers Market Value (US$ Mn) Forecast, by Application, 2017–2031
  • Table 21 : Latin America Cancer Biomarkers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22 : Latin America Cancer Biomarkers Market Value (US$ Mn) Forecast, by Type, 2017‒2031
  • Table 23 : Latin America Cancer Biomarkers Market Value (US$ Mn) Forecast, by Type of Cancer, 2017–2031
  • Table 24 : Latin America Cancer Biomarkers Market Value (US$ Mn) Forecast, by Technology, 2017–2031
  • Table 25 : Latin America Cancer Biomarkers Market Value (US$ Mn) Forecast, by Application, 2017–2031
  • Table 26 : Middle East & Africa Cancer Biomarkers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27 : Middle East & Africa Cancer Biomarkers Market Value (US$ Mn) Forecast, by Type, 2017‒2031
  • Table 28 : Middle East & Africa Cancer Biomarkers Market Value (US$ Mn) Forecast, by Type of Cancer, 2017–2031
  • Table 29 : Middle East & Africa Cancer Biomarkers Market Value (US$ Mn) Forecast, by Technology, 2017–2031
  • Table 30 : Middle East & Africa Cancer Biomarkers Market Value (US$ Mn) Forecast, by Application, 2017–2031
  • Figure 1 : Global Cancer Biomarkers market Value (US$ Mn) Forecast, 2017–2031
  • Figure 2 : Global Cancer Biomarkers market Value Share, by Type, 2021
  • Figure 3 : Global Cancer Biomarkers market Value Share, by Profiling Technology, 2021
  • Figure 4 : Global Cancer Biomarkers market Value Share, by Cancer, 2021
  • Figure 5 : Global Cancer Biomarkers market Value Share, by Application, 2021
  • Figure 6 : Global Cancer Biomarkers market Value Share, by Region, 2021
  • Figure 7 : Global Cancer Biomarkers Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 8 : Global Cancer Biomarkers Market Attractiveness Analysis, by Type, 2022–2031
  • Figure 9 : Global Cancer Biomarkers Market Value (US$ Mn), by Protein, 2017‒2031
  • Figure 10 : Global Cancer Biomarkers Market Value (US$ Mn), by Genetic, 2017‒2031
  • Figure 11 : Global Cancer Biomarkers Market Value (US$ Mn), by Others, 2017‒2031
  • Figure 12 : Global Cancer Biomarkers Market Value Share Analysis, by Type of Cancer, 2021 and 2031
  • Figure 13 : Global Cancer Biomarkers Market Attractiveness Analysis, by Type of Cancer, 2022–2031
  • Figure 14 : Global Cancer Biomarkers Market Revenue (US$ Mn), by Lung, 2017–2031
  • Figure 15 : Global Cancer Biomarkers Market Revenue (US$ Mn), by Breast, 2017–2031
  • Figure 16 : Global Cancer Biomarkers Market Revenue (US$ Mn), by Leukemia, 2017–2031
  • Figure 17 : Global Cancer Biomarkers Market Revenue (US$ Mn), by Melonoma, 2017–2031
  • Figure 18 : Global Cancer Biomarkers Market Revenue (US$ Mn), by Colorectal, 2017–2031
  • Figure 19 : Global Cancer Biomarkers Market Revenue (US$ Mn), by Prostate, 2017–2031
  • Figure 20 : Global Cancer Biomarkers Market Revenue (US$ Mn), by Ovarian, 2017–2031
  • Figure 21 : Global Cancer Biomarkers Market Revenue (US$ Mn), by Liver, 2017–2031
  • Figure 22 : Global Cancer Biomarkers Market Revenue (US$ Mn), by Others, 2017–2031
  • Figure 23 : Global Cancer Biomarkers Market Value Share Analysis, by Technology, 2021 and 2031
  • Figure 24 : Global Cancer Biomarkers Market Attractiveness Analysis, by Technology, 2022–2031
  • Figure 25 : Global Cancer Biomarkers Market Revenue (US$ Mn), by Omics, 2017–2031
  • Figure 26 : Global Cancer Biomarkers Market Revenue (US$ Mn), by Imaging, 2017–2031
  • Figure 27 : Global Cancer Biomarkers Market Revenue (US$ Mn), by Immunoassay, 2017–2031
  • Figure 28 : Global Cancer Biomarkers Market Revenue (US$ Mn), by Bioinformatics, 2017–2031
  • Figure 29 : Global Cancer Biomarkers Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 30 : Global Cancer Biomarkers Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 31 : Global Cancer Biomarkers Market Revenue (US$ Mn), by Diagnostics, 2017–2031
  • Figure 32 : Global Cancer Biomarkers Market Revenue (US$ Mn), by R&D, 2017–2031
  • Figure 33 : Global Cancer Biomarkers Market Revenue (US$ Mn), by Prognostics, 2017–2031
  • Figure 34 : Global Cancer Biomarkers Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 35 : Global Cancer Biomarkers Market Attractiveness Analysis, by Region, 2022–2031
  • Figure 36 : North America Cancer Biomarkers Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 37 : North America Cancer Biomarkers Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 38 : North America Cancer Biomarkers Market Attractiveness Analysis, by Country, 2022–2031
  • Figure 39 : North America Cancer Biomarkers Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 40 : North America Cancer Biomarkers Market Attractiveness Analysis, by Type, 2022–2031
  • Figure 41 : North America Cancer Biomarkers Market Value Share Analysis, by Type of Cancer, 2021 and 2031
  • Figure 42 : North America Cancer Biomarkers Market Attractiveness Analysis, by Type of Cancer, 2022–2031
  • Figure 43 : North America Cancer Biomarkers Market Value Share Analysis, by Technology, 2021 and 2031
  • Figure 44 : North America Cancer Biomarkers Market Attractiveness Analysis, by Technology, 2022–2031
  • Figure 45 : North America Cancer Biomarkers Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 46 : North America Cancer Biomarkers Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 47 : Europe Cancer Biomarkers Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 48 : Europe Cancer Biomarkers Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 49 : Europe Cancer Biomarkers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 50 : Europe Cancer Biomarkers Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 51 : Europe Cancer Biomarkers Market Attractiveness Analysis, by Type, 2022–2031
  • Figure 52 : Europe Cancer Biomarkers Market Value Share Analysis, by Type of Cancer, 2021 and 2031
  • Figure 53 : Europe Cancer Biomarkers Market Attractiveness Analysis, by Type of Cancer, 2022–2031
  • Figure 54 : Europe Cancer Biomarkers Market Value Share Analysis, by Technology, 2021 and 2031
  • Figure 55 : Europe Cancer Biomarkers Market Attractiveness Analysis, by Technology, 2022–2031
  • Figure 56 : Europe Cancer Biomarkers Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 57 : Europe Cancer Biomarkers Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 58 : Asia Pacific Cancer Biomarkers Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 59 : Asia Pacific Cancer Biomarkers Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 60 : Asia Pacific Cancer Biomarkers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 61 : Asia Pacific Cancer Biomarkers Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 62 : Asia Pacific Cancer Biomarkers Market Attractiveness Analysis, by Type, 2022–2031
  • Figure 63 : Asia Pacific Cancer Biomarkers Market Value Share Analysis, by Type of Cancer, 2021 and 2031
  • Figure 64 : Asia Pacific Cancer Biomarkers Market Attractiveness Analysis, by Type of Cancer, 2022–2031
  • Figure 65 : Asia Pacific Cancer Biomarkers Market Value Share Analysis, by Technology, 2021 and 2031
  • Figure 66 : Asia Pacific Cancer Biomarkers Market Attractiveness Analysis, by Technology, 2022–2031
  • Figure 67 : Asia Pacific Cancer Biomarkers Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 68 : Asia Pacific Cancer Biomarkers Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 69 : Latin America Cancer Biomarkers Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 70 : Latin America Cancer Biomarkers Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031
  • Figure 71 : Latin America Cancer Biomarkers Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031
  • Figure 72 : Latin America Cancer Biomarkers Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 73 : Latin America Cancer Biomarkers Market Attractiveness Analysis, by Type, 2022–2031
  • Figure 74 : Latin America Cancer Biomarkers Market Value Share Analysis, by Type of Cancer, 2021 and 2031
  • Figure 75 : Latin America Cancer Biomarkers Market Attractiveness Analysis, by Type of Cancer, 2022–2031
  • Figure 76 : Latin America Cancer Biomarkers Market Value Share Analysis, by Technology, 2021 and 2031
  • Figure 77 : Latin America Cancer Biomarkers Market Attractiveness Analysis, by Technology, 2022–2031
  • Figure 78 : Latin America Cancer Biomarkers Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 79 : Latin America Cancer Biomarkers Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 80 : Middle East & Africa Cancer Biomarkers Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 81 : Middle East & Africa Cancer Biomarkers Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031
  • Figure 82 : Middle East & Africa Cancer Biomarkers Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031
  • Figure 83 : Middle East & Africa Cancer Biomarkers Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 84 : Middle East & Africa Cancer Biomarkers Market Attractiveness Analysis, by Type, 2022–2031
  • Figure 85 : Middle East & Africa Cancer Biomarkers Market Value Share Analysis, by Type of Cancer, 2021 and 2031
  • Figure 86 : Middle East & Africa Cancer Biomarkers Market Attractiveness Analysis, by Type of Cancer, 2022–2031
  • Figure 87 : Middle East & Africa Cancer Biomarkers Market Value Share Analysis, by Technology, 2021 and 2031
  • Figure 88 : Middle East & Africa Cancer Biomarkers Market Attractiveness Analysis, by Technology, 2022–2031
  • Figure 89 : Middle East & Africa Cancer Biomarkers Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 90 : Middle East & Africa Cancer Biomarkers Market Attractiveness Analysis, by Application, 2022–2031

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Transparency
Price: $5795

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS